Beneo introduces filler-binder for effervescent tablets

Published: 18-Oct-2021

Manufacturing effervescent dosage forms is often challenging

Beneo has introduced galenIQ 721, a filler-binder is designed to enable pharmaceutical and nutraceutical manufacturers to target consumers that have difficulty swallowing standard tablets. A non-hygroscopic, water-soluble and directly compressible excipient, the product also provides content uniformity and production efficiency for effervescent applications, the company says.

Effervescent powders and tablets offer a more convenient way to deliver medicines or dietary supplements. They dissolve upon contact with water to release carbon dioxide and create a drink. In addition, Beneo says, they can be used to formulate pharmaceuticals that are difficult to digest, that cause stomach or esophageal irritation or that rely on a rapid onset of action, such as analgesics.

Manufacturing effervescent dosage forms is often challenging, however. To produce highly stable tablets, a non-hygroscopic, direct compression filler-binder is needed. This ensures high content uniformity and facilitates production.

Dr Maj-Britt Cepok, Head of Business Development, Pharma, Beneo, comments: “Fizzy tablets are ideally suited to administer a wide range of light-, oxygen- and other sensitive active ingredients and those that require a large dose. In addition, effervescent preparations are more appealing to consumers than traditional dosage forms. galenIQ 721 helps manufacturers to tap into this market and enhance their development programs.”

Relevant companies

You may also like